Work

Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.4528

Authors: Andrea B. Apolo, John Allan Ellerton, Jeffrey R. Infante, Manish Agrawal, Michael S. Gordon, Raid Aljumaily, Carolyn D. Britten, Luc Yves Dirix, Keun-Wook Lee, Matthew H. Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Arnold Gelb, Junyuan Xiong, Galit Rosen, Manish R. Patel

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Nevada Cancer Research Foundation, Tennessee Oncology, HonorHealth, Pinnacle Oncology Hematology, University of Oklahoma Medical Center, Medical University of South Carolina, Seoul National University Bundang Hospital, Oregon Health & Science University, OHSU Knight Cancer Institute, Universitair Ziekenhuis Leuven, Henry Ford Health, Hôpital Saint-André, EMD Serono, Inc. (United States), Florida Cancer Specialists & Research Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2736085757

Cites:

Cited by: 35

Related to: 10